China Meheco Group Co

China Meheco Group Co Dividend Coverage

The Dividend Coverage Ratio of China Meheco Group Co (600056.SS) as of Oct 22, 2026 is 16.09. In the previous year, Dividend Coverage Ratio was 1.54 — a change of 942.59% (higher).

Dividend Coverage

16.09

YoY

942.59%

Last updated:

Dividend Coverage Ratio of China Meheco Group Co is 2025 16.09 . Dividend Coverage Ratio of China Meheco Group Co was 2024 1.54 . It decreases by 942.59% higher compared to the previous year.

The China Meheco Group Co Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2018
5.55 CNY
Jan 1, 2019
2.96 CNY
Jan 1, 2020
6.23 CNY
Jan 1, 2021
1.65 CNY
Jan 1, 2022
2.71 CNY
Jan 1, 2023
4.75 CNY
Jan 1, 2024
1.54 CNY
Jan 1, 2025
16.09 CNY
The China Meheco Group Co Dividend Coverage history
YEARDividend CoverageYoY
16.09+942.59%
1.54-67.50%
4.75+75.43%
2.71+64.44%
1.65-73.59%
6.23+110.25%
2.96-46.60%
5.55-14.10%
6.46+29.74%
4.98-4.42%
5.21-1.37%
5.28—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

China Meheco Group Co Stock analysis

What does China Meheco Group Co do? China Meheco Group Co., Ltd. generates revenue through its Industrial Pharmaceutical segment, which manufactures and distributes chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces. The Commercial Pharmaceutical segment focuses on wholesale and distribution of pharmaceuticals and medical devices. The Trading segment handles international exporting and medical resourcing introduction. The company serves healthcare providers, hospitals, and pharmacies through its wholesale operations, targeting the pharmaceutical and medical device markets in China and internationally. The Industrial Pharmaceutical segment produces chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces for distribution. The Commercial Pharmaceutical segment supplies pharmaceuticals and medical devices to healthcare institutions and retailers. The Trading segment facilitates international exports of pharmaceutical products and introduces medical resources globally, catering to global healthcare markets. China Meheco's revenue streams are derived from the sale of pharmaceutical products across its three segments. The Industrial segment manufactures and sells chemical and traditional Chinese medicine products, while the Commercial segment distributes these products through wholesale channels. The Trading segment earns from exporting pharmaceuticals and managing international medical resource procurement for global clients. China Meheco Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about China Meheco Group Co stock

Dividend Coverage Ratio of China Meheco Group Co is 16.09 in 2025.

Dividend Coverage Ratio of China Meheco Group Co changed from 1.54 to 16.09, representing a 942.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio China Meheco Group Co since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's China Meheco Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — China Meheco Group Co

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — China Meheco Group Co